Literature DB >> 18079613

Effect of dietary fiber in edible seaweeds on the development of D-galactosamine-induced hepatopathy in rats.

Naoko Kawano1, Yukari Egashira, Hiroo Sanada.   

Abstract

Previous studies in our laboratory demonstrated the repressive effect of seaweeds (Laminaria sp., Sargassum fulvellum, Eisenia bicyclis and Gelidium sp.) against D-galactosamine (D-GalN)-induced hepatopathy. However, the mechanism by which these four seaweeds attenuate the D-GalN-hepatopathy has not been completely clarified. This study was carried out to determine the constituents of these seaweeds that protect rats against the D-GalN-hepatopathy. Male Wistar rats were fed for 8 d diets containing 5% seaweeds with or without the antibiotic neomycin (NEO) in experiment 1, and typical seaweed dietary fibers (laminaran, fucoidan, alginate, agar and kappa-carrageenan) of these seaweeds in experiment 2. On the 7th day, the rats were treated with D-GalN (1,900 mg in experiment 1 and 800 mg/kg in experiment 2) and then sacrificed 24 h after the injection of D-GalN. Their serum transaminase (aspartate and alanine aminotransferases: AST and ALT) activities were then determined. In experiment 1, the serum AST and ALT levels in the rats fed the four kinds of seaweeds without NEO were significantly low in comparison to that of the control group, but those with NEO were not significantly different among the groups. In experiment 2, the serum AST and ALT levels in the rats fed fucoidan were significantly low in comparison to those of the other groups fed the dietary fibers and the control. These results suggest that the protective effect of the three kinds of brown seaweeds Laminaria sp., Sargassum fulvellum and Eisenia bicyclis against D-GalN-hepatopathy was caused at least in part by fucoidan.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18079613     DOI: 10.3177/jnsv.53.446

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  5 in total

Review 1.  Therapies from fucoidan; multifunctional marine polymers.

Authors:  Janet Helen Fitton
Journal:  Mar Drugs       Date:  2011-09-30       Impact factor: 6.085

Review 2.  Marine polysaccharides from algae with potential biomedical applications.

Authors:  Maria Filomena de Jesus Raposo; Alcina Maria Bernardo de Morais; Rui Manuel Santos Costa de Morais
Journal:  Mar Drugs       Date:  2015-05-15       Impact factor: 5.118

Review 3.  Fucoidan: structure and bioactivity.

Authors:  Bo Li; Fei Lu; Xinjun Wei; Ruixiang Zhao
Journal:  Molecules       Date:  2008-08-12       Impact factor: 4.411

4.  Sargassum fulvellum Protects HaCaT Cells and BALB/c Mice from UVB-Induced Proinflammatory Responses.

Authors:  Chan Lee; Gyu Hwan Park; Eun Mi Ahn; Chan-Ik Park; Jung-Hee Jang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-09       Impact factor: 2.629

Review 5.  Pharmaceutical and Nutraceutical Potential Applications of Sargassum fulvellum.

Authors:  Jian Liu; Sibusiso Luthuli; Qifang Wu; Mingjiang Wu; Jong-Il Choi; Haibin Tong
Journal:  Biomed Res Int       Date:  2020-10-14       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.